Literature DB >> 3940769

Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience.

J K Mansel, A R Zinsmeister, P C Pairolero, J R Jett.   

Abstract

During a ten-year period, 66 patients with known primary colorectal adenocarcinoma underwent thoracotomy for pulmonary metastases. The median post-thoracotomy survival was 3.5 years and the cumulative survival at five years was 38 percent. The number of pulmonary metastases was significantly associated with post-thoracotomy survival (p less than .001). Patients with a solitary metastasis had a better survival than those with multiple pulmonary metastases. The association of disease-free interval and post-thoracotomy survival was of borderline significance (p = 0.1). Age, sex, grade of tumor, location of primary cancer, location of pulmonary metastases, size of resected metastases, initial stage of the primary colorectal cancer and the type of pulmonary resection had no influence on post-thoracotomy survival.

Entities:  

Mesh:

Year:  1986        PMID: 3940769     DOI: 10.1378/chest.89.1.109

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

Review 1.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis.

Authors:  Mitsuhiro Kamiyoshihara; Hitoshi Igai; Natsuko Kawatani; Takashi Ibe; Naoki Tomizawa; Kai Obayashi; Kimihiro Shimizu; Izumi Takeyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-08

Review 3.  Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.

Authors:  Francesca Fiorentino; Ian Hunt; Kristine Teoh; Tom Treasure; Martin Utley
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

4.  Validation of a nomogram for predicting overall survival after resection of pulmonary metastases from colorectal cancer at a single center.

Authors:  Yukihide Kanemitsu; Tomoyuki Kato; Koji Komori; Takayuki Fukui; Tetsuya Mitsudomi
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

Review 5.  Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

6.  Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma.

Authors:  Jun Nakajima; Makoto Tanaka; Jun Matsumoto; Eriho Takeuchi; Takeshi Fukami; Shinichi Takamoto
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

7.  Minimally invasive surgery using the open magnetic resonance imaging system combined with video-assisted thoracoscopic surgery for synchronous hepatic and pulmonary metastases from colorectal cancer: report of four cases.

Authors:  Hiromichi Sonoda; Tomoharu Shimizu; Katsushi Takebayashi; Hiroyuki Ohta; Koichiro Murakami; Hisanori Shiomi; Shigeyuki Naka; Jun Hanaoka; Tohru Tani
Journal:  Surg Today       Date:  2014-08-07       Impact factor: 2.549

Review 8.  Surgery for colorectal liver metastases: The evolution of determining prognosis.

Authors:  Gaya Spolverato; Aslam Ejaz; Nilo Azad; Timothy M Pawlik
Journal:  World J Gastrointest Oncol       Date:  2013-12-15

9.  Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis.

Authors:  Masahiko Higashiyama; Ken Kodama; Naozumi Higaki; Koji Takami; Kohei Murata; Masao Kameyama; Hideoki Yokouchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

10.  Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative.

Authors:  Marilee Carballo; Mary S Maish; Dawn E Jaroszewski; Amy Yetasook; Karl Bauer; Robert B Cameron; E Carmack Holmes
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.